Literature DB >> 6099951

Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection.

P A Eggleston, J O Hendley, J M Gwaltney.   

Abstract

To test the hypothesis that viral respiratory infections cause symptoms by activating mucosal mast cells to release mediators active on vasculature and mucosal glands, the presence of histamine in nasal secretions was assessed during natural colds and rhinovirus infections. Secretions were collected either with saline washes of the nasal cavity or by forcibly blowing into a beaker, and histamine was assayed spectrofluorometrically. In blown secretions from uninfected subjects, large variations were seen between individuals (ranging from 3 +/- 2 to 59 +/- 32 ng/ml), and equally large variations were seen from day to day in given subjects. Infection with rhinovirus and with influenza A did not change these concentrations significantly. In general, both with blown nasal secretions and with nasal washes, histamine concentrations tended to be lower during infection. Concentration of another preformed mast cell mediator, TAME-esterase, also was not elevated during infection. Thus, these data do not support an hypothesis that mast cell activation occurs during rhinovirus infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099951     DOI: 10.3109/00016488409128538

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  14 in total

1.  A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers.

Authors:  P G Higgins; G I Barrow; D A Tyrrell
Journal:  Antiviral Res       Date:  1990-12       Impact factor: 5.970

2.  Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.

Authors:  S J Sperber; J V Sorrentino; D K Riker; F G Hayden
Journal:  Bull N Y Acad Med       Date:  1989-01

Review 3.  Chemotherapy of rhinovirus colds.

Authors:  S J Sperber; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 4.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

5.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.

Authors:  R F Lemanske; E C Dick; C A Swenson; R F Vrtis; W W Busse
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 6.  Rhinitis as a mechanism of respiratory defense.

Authors:  R Eccles
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Induction and relief of nasal congestion in ferrets infected with influenza virus.

Authors:  K S Chen; S S Bharaj; E C King
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

Review 8.  Rhinoviruses, allergic inflammation, and asthma.

Authors:  Monica L Gavala; Paul J Bertics; James E Gern
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 9.  Cromolyns: treatment for the common cold.

Authors:  S L Johnston
Journal:  Clin Exp Allergy       Date:  1996-09       Impact factor: 5.018

10.  The Use of Antiallergic and Antiasthmatic Drugs in Viral Infections of the Upper Respiratory Tract.

Authors:  Nils Åberg
Journal:  Clin Immunother       Date:  2012-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.